Layla Al-Nakkash Selected Research

Genistein

1/2022	Systematic review of the impact of genistein on diabetes-related outcomes.
1/2022	Genistein: A focus on several neurodegenerative diseases.
11/2020	Exercise and/or Genistein Treatment Impact Gut Microbiota and Inflammation after 12 Weeks on a High-Fat, High-Sugar Diet in C57BL/6 Mice.
1/2020	Beneficial Effect of Genistein on Diabetes-Induced Brain Damage in the ob/ob Mouse Model.
11/2019	Bone Strength Is Improved with Genistein Treatment in Mice with Diet-Induced Obesity.
1/2019	Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice.
10/2018	High-fat, high-sugar diet induces splenomegaly that is ameliorated with exercise and genistein treatment.
10/2018	Consuming Genistein Improves Survival Rates in the Absence of Laxative in ΔF508-CF Female Mice.
4/2018	Feeding Obese Diabetic Mice a Genistein Diet Induces Thermogenic and Metabolic Change.
1/2017	Genistein treatment improves fracture resistance in obese diabetic mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Layla Al-Nakkash Research Topics

Disease

11	Obesity 11/2020 - 01/2014
10	Body Weight (Weight, Body) 01/2022 - 12/2010
6	Inflammation (Inflammations) 01/2022 - 01/2016
4	Hyperglycemia 04/2020 - 10/2018
4	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 01/2014
4	Weight Gain 01/2020 - 01/2016
3	Insulin Resistance 01/2022 - 04/2018
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 02/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2014
2	Neuroinflammatory Diseases 10/2020 - 01/2020
2	Bone Fractures (Bone Fracture) 11/2019 - 02/2019
2	Dysbiosis 01/2019 - 09/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Colitis 01/2020
1	Morbid Obesity 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2019
1	Splenomegaly 10/2018
1	Intestinal Diseases (Diseases, Intestinal) 10/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 09/2017
1	Endometriosis 09/2017
1	Endometrial Neoplasms (Endometrial Cancer) 09/2017
1	Hyperplasia 09/2017
1	Diabetes Mellitus 01/2017
1	Hypertrophy 12/2016
1	Right Ventricular Hypertrophy 12/2016
1	Pulmonary Hypertension 12/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Ischemia 09/2009
1	Heart Diseases (Heart Disease) 09/2009

Drug/Important Bio-Agent (IBA)

18	GenisteinIBA 01/2022 - 09/2009
3	IsoflavonesIBA 01/2022 - 04/2018
3	Insulin (Novolin)FDA Link 01/2022 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
3	SugarsIBA 11/2020 - 10/2018
3	ResveratrolIBA 10/2020 - 12/2016
3	LeptinIBA 01/2019 - 01/2014
3	Estrogens (Estrogen)FDA Link 09/2017 - 12/2010
3	Phytoestrogens (Phytoestrogen)IBA 01/2016 - 09/2009
2	Neuroprotective AgentsIBA 01/2022 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 10/2020 - 01/2020
2	Amyloid beta-PeptidesIBA 10/2020 - 01/2020
2	CorticosteroneIBA 04/2018 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2014
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2015 - 01/2015
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2015 - 01/2012
2	ChloridesIBA 01/2015 - 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	PolyphenolsIBA 10/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2020
1	LipidsIBA 01/2019
1	EndotoxinsIBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2018
1	FructoseIBA 10/2018
1	Sucrose (Saccharose)IBA 10/2018
1	Drinking WaterIBA 10/2018
1	LaxativesIBA 10/2018
1	GlucocorticoidsIBA 04/2018
1	Thyroid HormonesIBA 04/2018
1	MonocrotalineIBA 12/2016
1	Free RadicalsIBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	Vasodilator Agents (Vasodilators)IBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Chloride Channels (Chloride Channel)IBA 01/2015
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2014
1	Glucose Transporter Type 5IBA 01/2014
1	villinIBA 01/2014
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2014

Therapy/Procedure

3	Injections 01/2015 - 12/2010
1	Subcutaneous Injections 01/2015
1	Aftercare (After-Treatment) 09/2009